Back to search
FDAFDA · Food and drugs·Recall number D-0413-2015

Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10

Published March 25, 2015 · Recall initiated: January 23, 2015

Summary

FDA records drug Class III recall D-0413-2015, published March 25, 2015 and initiated January 23, 2015. Recalling firm: Mylan Institutional LLC; Status: Terminated; Reported quantity: 78,090 vials; Lot: Lot #: UW301, UW302, Exp 02/15; UW303, UW304, UW305, UW306, Exp 04/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent Drug and Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mylan Institutional LLC
Distributor
Nationwide
Lot
Lot #: UW301, UW302, Exp 02/15; UW303, UW304, UW305, UW306, Exp 04/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Nicardipine Hydrochloride Injection, 25 mg/10 ml (2.5 mg/mL),10 mL single dose vial, Rx only, Manufactured in India for: Mylan Institutional LLC, Rockford, IL 61103, NDC 67457-224-10 recalled?

Yes. FDA published recall D-0413-2015 on March 25, 2015. Reported hazard: Subpotent Drug and Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter